TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
GlaxoSmithKline Pharma A/S
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
548,470
|
474,477
|
440,283 |
| Earnings before taxes |
16,265
|
15,463
|
14,341 |
| Total assets |
99,094
|
117,324
|
115,803 |
| Current assets |
97,073
|
114,939
|
113,054 |
| Current liabilities |
60,965
|
79,435
|
78,647 |
| Equity capital |
38,129
|
37,889
|
36,946 |
| - share capital |
10,000
|
10,000
|
10,000 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.5%
|
32.3%
|
31.9% |
| Turnover per employee |
7,313
|
6,326
|
5,870 |
| Profit as a percentage of turnover |
3.0%
|
3.3%
|
3.3% |
| Return on assets (ROA) | |||
| Current ratio |
159.2%
|
144.7%
|
143.7% |
| Return on equity (ROE) |
42.7%
|
40.8%
|
38.8% |
| Change turnover |
73,993
|
34,194
|
-5,590 |
| Change turnover % |
16%
|
8%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.